HENRY CATCHPOLE TAKES TO THE TRACK IN RARE HONDA NSX-R IN SWEDEN AHEAD OF BROAD ARROW’S FIRST EUROPEAN AUCTION

2 days ago

HIGHLY COLLECTIBLE NSX-R TO FEATURE IN INAUGURAL BROAD ARROW CONCORSO D'ELEGANZA VILLA D'ESTE AUCTION ON 24-25 MAY 2003 Honda NSX-R…

Compass Therapeutics Reports 2025 First Quarter Financial Results and Provides Corporate Update

2 days ago

Tovecimig (DLL4 x VEGF-A bispecific antibody) met the primary endpoint in the ongoing randomized Phase 2/3 Study in patients with…

D-BOX and Cinemark Announce Expansion with the Addition of Over 70 New D-BOX Haptic-Enabled Screens

2 days ago

Expansion represents an increase of nearly 25% across new and existing markets in the U.S.MONTREAL, May 08, 2025 (GLOBE NEWSWIRE)…

DRONEPORT NETWORK SELECTS RESILIENX FOR DEVELOPMENT OF GROUNDBREAKING BEYOND VISUAL LINE OF SIGHT (BVLOS) AIRSPACE ENVIRONMENT IN TULSA

2 days ago

Droneport Network and Resilienx Droneport Network and Resilienx logos on Tulsa skyline Tulsa, OK, May 08, 2025 (GLOBE NEWSWIRE) --…

RAPT Therapeutics Reports First Quarter 2025 Financial Results

2 days ago

SOUTH SAN FRANCISCO, Calif., May 08, 2025 (GLOBE NEWSWIRE) -- RAPT Therapeutics, Inc. (Nasdaq: RAPT) (“RAPT” or the “Company”), a…

Perma-Fix Reports Q1 2025 Results and Highlights Momentum in Hanford and PFAS Programs

2 days ago

Improved gross margins and rising backlog driven by increased waste receipts Strategic investments expected to position the Company for stronger performance…

Cassava Reports Q1 2025 Financials Results, Provides Business Update

2 days ago

License agreement and recent leadership appointments position Cassava to advance development of simufilam in TSC-related epilepsy $117.3 Million in Cash…

U.S. Online Shoppers Can Try on Their Next Fashion Purchase Using a 3D Avatar

2 days ago

- Online sizing technology provider, Makip, has upgraded its flagship product, Unisize, to provide a 3D avatar sizing display as…

Protara Therapeutics Announces First Quarter 2025 Financial Results and Provides Business Update

2 days ago

Reported positive interim results demonstrating durable responses in the ongoing Phase 2 ADVANCED-2 trial of TARA-002 in NMIBC Results from…

Artiva Biotherapeutics Reports First Quarter 2025 Financial Results, Recent Business Highlights

2 days ago

IND clearance and initiation of global basket trial exploring AlloNK® + rituximab in refractory rheumatoid arthritis, Sjögren’s disease, idiopathic inflammatory…

This website uses cookies.